Inventor · disambiguated record
Adam Galan
Also filed as: GALAN ADAM · GALAN ADAM A · GALAN ADAM ANTONI
17 granted patents·9 pending applications·222 citations·filing 1993–2025
93Inventor score
Top patents by PatentIndex Score
26 records- 0196US11286260B2P38α mitogen-activated protein kinase inhibitorsGEN1E LIFESCIENCES INC·Filed 2021·Granted Mar 29, 2022·12 cites·30 claims
- 0295US11555020B2Substituted naphthyl p38α mitogen-activated protein kinase inhibitorsGEN1E LIFESCIENCES INC·Filed 2022·Granted Jan 17, 2023·4 cites·22 claims
- 0395US11440918B2p38α mitogen-activated protein kinase inhibitorsGEN1E LIFESCIENCES INC·Filed 2022·Granted Sep 13, 2022·5 cites·29 claims
- 0495US11390581B2Crystalline 5-(dimethylamino)-n-(4-(morpholinomethyl)phenyl)naphthalene-1-sulfonamide di-hydrochloride di-hydrateGEN1E LIFESCIENCES INC·Filed 2021·Granted Jul 19, 2022·2 cites·27 claims
- 0592US11744876B2Immunomodulator antibody drug conjugates and uses thereofSUTRO BIOPHARMA INC·Filed 2020·Granted Sep 5, 2023·4 cites·47 claims
- 0692US5863936ATelomerase inhibitorsGERON CORP·Filed 1995·Granted Jan 26, 1999·71 cites·22 claims
- 0791US11926635B2P38α mitogen-activated protein kinase inhibitorsGEN1E LIFESCIENCES INC·Filed 2022·Granted Mar 12, 2024·1 cites·35 claims
- 0888US12116353B1Crystalline chloro-n-(4-(morpholinomethyl)phenyl)benzamide and crystalline hydrochloride saltGEN1E LIFESCIENCES INC·Filed 2024·Granted Oct 15, 2024·2 cites·15 claims
- 0988US5760062ATelomerase inhibitorsGERON CORP·Filed 1995·Granted Jun 2, 1998·56 cites·9 claims
- 1085US5703116ATelomerase InhibitorsGERON CORP·Filed 1995·Granted Dec 30, 1997·38 cites·22 claims
- 1184US12331024B2Substituted naphthyl P38alpha mitogen-activated protein kinase inhibitorsGEN1E LIFESCIENCES INC·Filed 2024·Granted Jun 17, 2025·0 cites·32 claims
- 1282US12404259B2Inhibitors of extracellular signal-regulated kinaseGEN1E LIFESCIENCES INC·Filed 2024·Granted Sep 2, 2025·0 cites·12 claims
- 1382US2024182486A1P38alpha mitogen-activated protein kinase inhibitorsGEN1E LIFESCIENCES INC·Filed 2024·Application pending·0 cites
- 1479US11976049B2Substituted naphthyl p38alpha mitogen-activated protein kinase inhibitorsGEN1E LIFESCIENCES INC·Filed 2022·Granted May 7, 2024·0 cites·17 claims
- 1579US8440663B24-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as JAK-2 modulators and methods of useMANN GRACE·Filed 2007·Granted May 14, 2013·7 cites·33 claims
- 1679US2025270176A1Substituted naphthyl p38alpha mitogen-activated protein kinase inhibitorsGEN1E LIFESCIENCES INC·Filed 2025·Application pending·0 cites
- 1777US2025353826A1Inhibitors of extracellular signal-regulated kinaseGEN1E LIFESCIENCES INC·Filed 2025·Application pending·0 cites
- 1876US5346911AAzabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatmentWARNER LAMBERT CO·Filed 1993·Granted Sep 13, 1994·17 cites·12 claims
- 1974US2025243154A1Crystalline 5-(dimethylamino)-n-(4-(morpholinomethyl)phenyl)naphthalene-1-sulfonamide di-hydrochloride di-hydrateGEN1E LIFESCIENCES INC·Filed 2025·Application pending·0 cites
- 2073US12269792B2Crystalline 5-(dimethylamino)-N-(4-(morpholinomethyl) phenyl)naphthalene-1-sulfonamide di-hydrochloride di-hydrateGEN1E LIFESCIENCES INC·Filed 2022·Granted Apr 8, 2025·0 cites·20 claims
- 2171US2025333387A1Crystalline chloro-n-(4-(morpholinomethyl)phenyl)benzamide and crystalline hydrochloride saltGEN1E LIFESCIENCES INC·Filed 2024·Application pending·0 cites
- 2269US8088767B2JAK-2 modulators and methods of useGALAN ADAM ANTONI·Filed 2007·Granted Jan 3, 2012·3 cites·12 claims
- 2369US2024139285A1Immunomodulator antibody drug conjugates and uses thereofSUTRO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 2461US2025361253A1Sting agonist compoundsSUTRO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 2549US2009247559A1BenzofuropyrimidinonesEXELIXIS INC·Filed 2008·Application pending·0 cites
- 2645US2007208166A1Tao Kinase Modulators And Method Of UseEXELIXIS INC·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Adam Galan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →